CCM chief defends demerger exercise


KUALA LUMPUR: Chemical Company of Malaysia Bhd’s (CCM) head honcho has defended the company’s demerger exercise as one that will not result in any losses to shareholders.

Speaking to reporters at a briefing here yesterday, CCM group managing director Leonard Ariff Abdul Shatar acknowledged that it would take time for the market to digest the recently announced corporate exercise to de-gear and demerge from its profit-making pharmaceutical unit CCM Duopharma Biotech Bhd.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , CCM , CCM Duopharma , demerger , stock , shares ,

Next In Business News

MSPO certification helps Malaysia meet sustainability requirements in FTAs, says MPOB
Teamstar signs underwriting agreement with TA Securities for ACE Market IPO
Melati Ehsan redesignates COO to CEO
TM Nxera partners with TNB to secure 280MW for data centre campus
Favelle Favco acquires France-based Seram Industries SAS
Ringgit ends firmer as concerns over Fed independence weigh on US dollar
HE Group wins power distribution system contract
Awanbiru appoints Azizah Ali as its group CEO
MN Holdings proposes transfer to the Main Market of Bursa Securities
Vantris Energy divests stake in L&T-Sapura Shipping for 124mil

Others Also Read